Evidence map›Paper›PMID 38694272›Full record

ArticleFrontiers in neural circuits2024

Immunolabeling-compatible PEGASOS tissue clearing for high-resolution whole mouse brain imaging.

Pan Gao, Matthew Rivera, Xiaoxiao Lin, Todd C Holmes, Hu Zhao, Xiangmin Xu

Open access · goldAbstract read
In one paragraph

Article in Frontiers in neural circuits, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.3field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Chemoarchitectural studies of the rat hypothalamus and zona incerta.bioRxiv : the preprint server for biology · 2025
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Pan GaoDepartment of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, Irvine, CA, United States.
Matthew RiveraDepartment of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, Irvine, CA, United States.
Xiaoxiao LinDepartment of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, Irvine, CA, United States.
Todd C HolmesDepartment of Physiology and Biophysics, School of Medicine, University of California, Irvine, Irvine, CA, United States.
Hu ZhaoChinese Institute for Brain Research, Beijing, China.
Xiangmin XuDepartment of Anatomy and Neurobiology, School of Medicine, University of California, Irvine, Irvine, CA, United States.
University of California, Irvine · USChinese Institute for Brain Research · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel brain clearing methods revolutionize imaging by increasing visualization throughout the brain at high resolution. However, combining the standard tool of immunostaining targets of interest with clearing methods has lagged behind. We integrate whole-mount immunostaining with PEGASOS tissue clearing, referred to as iPEGASOS (immunostaining-compatible PEGASOS), to address the challenge of signal quenching during clearing processes. iPEGASOS effectively enhances molecular-genetically targeted fluorescent signals that are otherwise compromised during conventional clearing procedures. Additionally, we demonstrate the utility of iPEGASOS for visualizing neurochemical markers or viral labels to augment visualization that transgenic mouse lines cannot provide. Our study encompasses three distinct applications, each showcasing the versatility and efficacy of this approach. We employ whole-mount immunostaining to enhance molecular signals in transgenic reporter mouse lines to visualize the whole-brain spatial distribution of specific cellular populations. We also significantly improve the visualization of neural circuit connections by enhancing signals from viral tracers injected into the brain. Last, we show immunostaining without genetic markers to selectively label beta-amyloid deposits in a mouse model of Alzheimer's disease, facilitating the comprehensive whole-brain study of pathological features.

Indexed as

Alzheimer DiseaseBrainMice, TransgenicAmyloid beta-PeptidesAnimalsImmunohistochemistryMiceMice, Inbred C57BLNeuroimagingAmyloid beta-PeptidesAlzheimer’s diseasecircuit tracingLight-Sheettissue clearingwhole-mount immunostaining

Identifiers

PMID38694272
PMCPMC11061518
OpenAlexW4394887369

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.